CAS: 1931944-80-7
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Donanemab REF: TM-T77162CAS: 1931944-80-7 | 95% | 270.00 €~2,218.00 € | Mon 21 Oct 24 | |
Donanemab REF: 3D-CLA1552CAS: 1931944-80-7 | - - - | To inquire | Tue 29 Oct 24 |
Donanemab
CAS:1931944-80-7
Donanemab (LY3002813), a humanized IgG1 antibody, targets N-terminal Aβ for potential early Alzheimer's research.
Purity:
95%
Color and Shape:
Solid
Ref: TM-T77162
1mg | 270.00 € | ||
5mg | 702.00 € | ||
10mg | 1,100.00 € | ||
25mg | 1,659.00 € | ||
50mg | 2,218.00 € |
Estimated delivery in United States, on Monday 21 Oct 2024
Donanemab
CAS:1931944-80-7
A humanized IgG1 monoclonal antibody targets Aβ N-terminal epitope (p3-42).
Ref: 3D-CLA1552
Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 29 Oct 2024